Residency Program

alt text

Abigail Hart Baird, MD, MHS - 3rd Year, Co-Chief

Undergraduate School: Wellesley College

Undergraduate Major: Biology

Medical School: Yale University School of Medicine

Research Fellowship: Doris Duke Clinical Research Fellowship

Internship: Transitional Year at Memorial Sloan Kettering Cancer Center

alt text

Teri Greiling MD, PhD - 3rd Year, Co-Chief

Undergraduate School: University of Washington

Undergraduate Major: Neurobiology

Medical School: University of Washington School of Medicine

Additional Training: Phd in Biological Structure - University of Washington

Internship: Transitional Year at Virginia Mason Medical Center

alt text

Evelyn Lilly, MD - 3rd Year, Co-Chief

Undergraduate School: Harvard College

Undergraduate Major: Neurobiology

Medical School: Harvard Medical School

Internship: Northwestern Memorial Hospital

alt text

Julia Pettersen, MD - 3rd Year, Co-Chief

Undergraduate School: Duke University

Undergraduate Major: English

Medical School: Mount Sinai School of Medicine

Internship: Internal Medicine at The Mount Sinai Hospital

alt text

David Khalil, MD - 2nd Year

Undergraduate School: Princeton University

Undergraduate Major: Chemistry

Medical School: Albert Einstein College of Medicine

Additional Training: Postdoctoral Fellow, Immunotherapy, Yale University

Internship: Yale-New Haven Hospital - Internal Medicine

alt text

Jonathan Scott Leventhal, MD - 2nd Year

Undergraduate School: New York University

Undergraduate Major: Biology

Medical School: New York University School of Medicine

Internship: Winthrop University - Internal Medicine


alt text

Ian Odell, MD, PhD - 2nd Year

Undergraduate School: Cornell University

Undergraduate Major: Computational Biology

Medical School: University of Vermont

Additional Training: PhD, Microbiology and Molecular Genetics - University of Vermont

Internship: Fletcher Allen Health Care, University of Vermont - Internal Medicine

alt text

Kathleen Cook Suozzi, MD - 2nd Year

Undergraduate School: Duke University

Undergraduate Major: Biology

Medical School: New York University School of Medicine

Additional Training: HHMI Medical Research Fellow

Internship: Memorial Sloan-Kettering Cancer Center Transitional Year Internship

alt text

William Damsky, MD, PhD - 1st Year

Undergraduate School: University of Vermont

Undergraduate Major: Biology

Medical School: University of Vermont College of Medicine

Additional Training: PhD, Cell and Molecular Biology, University of Vermont College of Medicine

Internship: Yale Internal Medicine Traditional Preliminary

alt text

Lauren Lee Levy, MD - 1st Year

Undergraduate School: University of Pennsylvania

Undergraduate Major: Biological Basis of Behavior

Medical School: Mount Sinai School of Medicine

Additional Training: Doris Duke Clinical Research Fellowship

Internship: Memorial Sloan Kettering Cancer Center

alt text

Mariam Totonchy, MD - 1st Year

Undergraduate School: Duke University

Undergraduate Major: Biology & History

Medical School: UCLA David Geffen School of Medicine

Additional Training: Clinical Research Training Program Fellowship, 

National Institutes of Health

Internship: Kaiser Permanente Los Angeles Medical Center, Internal Medicine

alt text

Matthew David Vesely, MD, PhD - 1st Year

Undergraduate School: Creighton University

Undergraduate Major: Biology & Theology

Medical School: Washington University School of Medicine, St. Louis

Additional Training: PhD Immunology, Washington University School of Medicine

Internship: Preliminary Medicine, Barnes-Jewish Hospital

Publications

Berger, CL, Hoffmann K, Vasquez JG, Mane S, Lin A, Zhao H, Durazzo T, Baird A, Lin W, Foss F, Christensen I, Girardi M, Tigelaar R, Edelson R. Rapid Generation of Maturationally Synchronized Human Dendritic Cells: Contribution to the Clinical Efficacy of Extracorporeal Photochemotherapy. Blood. 2010;116(23):4838-47.



McEvoy SD, DiLuna ML, Baird AH, Duncan CC. Symptomatic thoracic Tarlov perineural cyst. Pediatr Neurosurg. 2009;45(4):321-3


Mroz EA, Baird AH, Michaud WA, Rocco JW. COOH-terminal binding protein regulates expression of the p16INK4A tumor suppressor and senescence in primary human cells. Cancer Research 2008;68:6049-6053.


GreilingTMS

, Clark JI. New Insights into the Mechanism of Lens Development using zebra fish. International Review of Cell and Molecular Biology. 2012;296:1-61


Greiling TMS

, Aose M, Clark JI. Cell Fate and Differentiation in the Zebrafish Lens. Investigative Ophthalmology and Visual Science. 2010 Mar;51(3):1540-6


Greiling TMS

, Houck SA, Clark JI. The Zebrafish Lens Proteome during Development and Aging. Molecular Vision. 2009 Nov 13;15:2313-25


Greiling TMS

, Clark JI. Early lens development in the zebrafish: a 3-dimensional time-lapse analysis. Developmental Dynamics 2009 Sep;238(9):2254-65


Greiling TMS

, Stone B, Clark JI. Absence of SPARC leads to impaired lens circulation. Experimental Eye Research 2009 Sep;89(3):416-25


Greiling TMS

, Clark JI. The transparent lens and cornea in the mouse and zebra fish eye. Seminars in Cell and Developmental Biology 2008 Apr;19(2):94-9


Muchowski PJ, Ramsden R, Nguyen Q, Arnett EE, Greiling TM, Anderson SK, Clark JI. Noninvasive measurement of protein aggregation by mutant Huntingtin fragments or alpha-Synuclein in the lens. Journal of Biological Chemistry 2008 Mar 7;283(10):6330-6.


Lilly E

, Kundu R. Dermatoses secondary to Asian cultural practices. Int J of Dermatol. 2012 Apr; 51 (4): 372-9.


Lilly E

, et al. Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL). JAAD 2012 Feb. 


Pettersen JS, 

Fuentes-Duculan J, Suárez-Fariñas M, Pierson KC, Pitts-Kiefer A, Fan L, Belkin DA, Wang CQ, Bhuvanendran S, Johnson-Huang LM, Bluth MJ, Krueger JG, Lowes MA, Carucci JA. Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated, J

ournal of Investigative Dermatology. 2011 Feb 10.


Moussai D, Mitsui H,

Pettersen JS

, Pierson K, Shah K, Suárez-Fariñas M, Cardinale I, Bluth M, Krueger J, Carucci J. The human cutaneous squamous cell carcinoma microenvironment is characterized by increased lymphatic density and enhanced expression of macrophage-derived VEGF-C. 

Journal of Investigative Dermatology. 2010 Sept 09.


Carucci, J.A. & Pettersen, J.S. (2012). Basal Cell Carcinoma. In L.A. Goldsmith, S.I. Katz, B.A. Gilchrest, D.J. Leffell, and K. Wolff (Ed.), Fitzpatrick's Dermatology in General Medicine, 8th Edition. New York, NY. McGraw-Hill.


Pettersen J, F

uentes-Duculan J, Suárez-Fariñas M, Pierson K, Pitts-Kiefer A, Moussai D., Bluth M, Krueger J, Lowes M, Carucci J. (2010, May). Poly-activated tumor-associated macrophages in cutaneous squamous cell carcinoma. Poster presented at: 2010 Society for Investigative Dermatology Annual Meeting; Atlanta, GA.


Bluth M, Pettersen J, Suarez-Farinas M, Moussai D, Fuentes-Duculan J, Krueger J, Carucci J. (2010, May). Regulatory T cells are associated with the human cutaneous SCC microenvironment and suppress activation of naïve T cells stimulated by CD3/28. Oral Presentation and Poster presented at: 2010 Society for Investigative Dermatology Annual Meeting; Atlanta, GA.


Khalil D, S

aluja S, Futterlieb J, Feng H, Filler R, Robinson E, Hanlon D, Girardi M, Tigelaar R, & Edelson R (2013). Inflaming the Human Antigen Presenting Cell Continuum. Journal of Investigative Dermatology,133, S8, Abstract 043. 


Saluja S, Khalil D, Robinson E, Sharp F, Fahmy T, Tigelaar R, Edelson R, & Hanlon D (2013). DEC-205 targeted nanoparticles for improved DC-based antigen delivery and cross-presentation. Journal of Investigative Dermatology. 133, S14, Abstract 082.


Saluja S, Hanlon D,

Kahlil D, 

Sharp F, Fadel T, Robinson E, Fahmy T, Tigelaar R, & Edelson R (2012).


Leventhal JS, F

arhadian JA, Miller KK, Tlougan BE, Patel RR, Sanchez MR. Crystal, Deodorant-Induced Axillary Granulomatous Dermatitis. Int J Dermatol,2013 April 28 [epub ahead of print]


Farhadian JA, Tlougan BE, Adams BB, Leventhal JS, Sanchez MR. Skin conditions in baseball, cricket and softball players. Sports Med,2013 March 2 [epub ahead of print]


Leventhal JS, Be

rger EM, Brauer JA, Cohen DE. Hypersensitivity Reactions to Vaccine Constituents: A Case Series and Review of the Literature. Dermatitis.2012;23(3):102-9


Leventhal JS, S

anchez MR. Is it time to reevaluate the treatment of pemphigus? J Drugs Dermatol. 2012;11(10):1200-06


Leventhal JS, Tl

ougan BE. Aquatic Sports Dermatoses: Clinical presentation and treatment guidelines. In K.R. Zaslav (Ed.), An International Perspective on Topics in Sports Medicine and Sports Injury. Richmond, VA: Intech Open Access Publisher; 2012: 223-244.


Leventhal JS, Tl

ougan BE. Sporotrichosis. In W.R.Heymann, B.E. Anderson, C.Hivnor, S.Lessin (Ed.), Clinical Decision Support: Dermatology. Wilmington, DE. Decision Support in Medicine, LLC, 2012.


Odell ID, C

ook D. “Immunofluorescence techniques.” J Invest Dermatol (2013). 133(1): e4.


Odell ID, W

allace SS, Pederson DS. “Rules of engagement for base excision repair in chromatin.” J Cell Physiol (2013). 228(2):258-66.


Odell ID, B

arbour J, Murphy DL, Della Maria JA, Sweasy JB, Tomkinson AE, Wallace SS, Pederson DS. “Nucleosome disruption by DNA Ligase III-XRCC1 promotes efficient base excision repair.” Mol Cell Biol (2011). 31(22):4623-32.


Odell ID, N

ewick K, Heintz NH, Wallace SS, Pederson DS. “Non-specific DNA binding interferes with the efficient excision of oxidative lesions from chromatin by the human DNA glycosylase, NEIL1.” DNA Repair (2010). 9(2):134-43. 


Hamilton B, Dong Y, Shindo M, Liu W, Odell ID, R

uvkun G, Lee SS. "A systematic RNAi screen for longevity genes in C. elegans." Genes Dev. (2005). 19(13):1544-55.


Odell ID, Cl

oud JL, Seipp M, Wittwer CT. “Rapid species identification within the Mycobacterium chelonae-abscessus group by high-resolution melting analysis of hsp65 PCR products.” Am J Clin Pathol. (2005). 123(1):96-101.


Suozzi KC, 

Wu X, Fuchs E. Spectraplakins: Master orchestrators of cytoskeletal dynamics. J. Cell Bio. 2012 May;197(4):465-475


Cook K., 

Wu X., Stokes N., Fuchs E. The role of adenomatous polyposis coli (APC) in epidermal development and hair follicle morphogenesis. Journal of Investigative Dermatology. 2011 Apr;131(Suppl):S44.


Leger M., Patel U., Mandal R., Walters R., Cook K., Haimovic A., Franks AG Jr. Glomangioma. Dermatology Online Journal. 2010 Nov;16(11):11.


Cook K.,

Brownell I. Treatments for Genital Warts. Journal of Drugs in Dermatology. 2008 Aug;7(8):801-7.


Melanoma metastasis: new concepts and evolving paradigms. 

Damsky WE, Theodosakis N, Bosenberg M. 

Oncogene. 2014 May 8;33(19):2413-22. doi: 10.1038/onc.2013.194. Epub 2013 Jun 3.


From bedding to bedside: genetically engineered mouse models of cancer inform concurrent clinical trials. 

Damsky WE, Bosenberg M. 

Pigment Cell Melanoma Res. 2012 Jul;25(4):404-5. doi: 10.1111/j.1755-148X.2012.01013.x. 


β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas. 

Damsky WE, Curley DP, Santhanakrishnan M, Rosenbaum LE, Platt JT, Gould Rothberg BE, Taketo MM, Dankort D, Rimm DL, McMahon M, Bosenberg M. 

Cancer Cell. 2011 Dec 13;20(6):741-54. doi: 10.1016/j.ccr.2011.10.030.


Unwelcome guests: macrophages promote UV-induced melanoma. 

Damsky WE, Bosenberg M. 

Pigment Cell Melanoma Res. 2011 Apr;24(2):265-7.


Mouse melanoma models and cell lines. 

Damsky WE Jr, Bosenberg M. 

Pigment Cell Melanoma Res. 2010 Dec;23(6):853-9. doi: 10.1111/j.1755-148X.2010.00777.x.



Decoding melanoma metastasis. 

Damsky WE, Rosenbaum LE, Bosenberg M. 

Cancers (Basel). 2010 Dec 30;3(1):126-63. doi: 10.3390/cancers3010126.


Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. 

Dankort D, Curley DP, Cartlidge RA, Nelson B, Karnezis AN, Damsky WE Jr, You MJ, DePinho RA, McMahon M, Bosenberg M. 

Nat Genet. 2009 May;41(5):544-52. doi: 10.1038/ng.356. Epub 2009 Mar 12.


Small AC, Levy LL. In support of medical student research. Acad Med. 2013 Nov;88(11):1592. doi: 10.1097/ACM.0b013e3182a7fa30.



Levy LL, Emer JJ. Female pattern alopecia: current perspectives. Int J Womens  Health. 2013 Aug 29;5:541-556. eCollection 2013. Review. PubMed PMID: 24039457; PubMed Central.  


Levy LL, Jiang N, Smouha E, Richards-Kortum R, Sikora AG. Optical imaging with a high-resolution microendoscope to identify cholesteatoma of the middle ear. Laryngoscope. 2013 Apr;123(4):1016-20. doi: 10.1002/lary.23710. Epub 2013 Jan 8.

PubMed.


Levy LL, Emer JJ. Emotional benefit of cosmetic camouflage in the treatment of facial skin conditions: personal experience and review. Clin Cosmet Investig Dermatol. 2012;5:173-82. doi: 10.2147/CCID.S33860. Epub 2012 Nov 1. PubMed.


Totonchy MB, Chiu MW. UV-Based therapy. Dermatol Clin, 2014 July; 32(3):399-413.


Viana LM, Seyyedi M, Brewer CC, Zalewski C, Digiovanna JJ, Tamura D, Totonchy M, Kraemer KH, Nadol JB Jr. Histopathology of the inner ear in patients with xeroderma pigmentosum and neurologic degeneration. Otol Neurotol. 2013 September; 34(7):1230-6


Totonchy

MB, Tamura D, Pantell M, Zalewski C, Bradord PT, Merchant SN, Griffith AJ, DiGiovanna JJ, Brewer CC and Kraemer KH. Auditory analysis of xeroderma pigmentosum, 1971-2012: Hearing function, acute sun sensitivity and DNA repair complementation group predict neurologic degeneration. Brain. 2013 January;136 (Pt 1):194-208


Lee EW, Wong D, Tafti BA, Prieto V,

Totonchy M

, Hilton J, Dry S, Cho S, Loh CT, Kee ST. Irreversible electroporation in eradication of rabbit VX2 liver tumor.

J Vasc Interv Radiol

. 2012 Jun; 23(6):833-40.


Lee, E.W., Totonchy, M.B., Kee, S. “Irreversible Electroporation and Ablation: Mechanism of Action and Devices.” Percutaneous Tumor Ablation: Strategies and Techniques. Eds. Kelvin Hong and Christos Georgiades. New York, NY: Thieme Medical Publishers, 2010.


Jockheck-Clark AR, Bowers EV,

Totonchy MB

, Neubauer J, Pizzo SV, Nicchitta CV. Re-Examination of CD91 function in GRP94 (glycoprotein 96) surface binding, Uptake, and Peptide Cross-Presentation.

Journal of Immunology

. 2010 Dec 1; 185 (11): 6819-30.


Lee J, Son MJ, Woolard K, Donin NM, Li A, Cheng CH, Kotliarova S, Kotliarov Y, Walling J, Ahn S, Kim M,

Totonchy M

, Cusack T, Ene C, Ma H, Su Q, Zenklusen JC, Zhang W, Maric D, Fine HA. Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells.

Cancer Cell

. 2008;13(1):69-80.


Vesely MD

, Vesely DL. Environmental upregulation of the atrial natriuretic peptide in the living fossil, Limulus polyphemus. Biochem Biophys Res Commun. 1999; 254(3): 751-6.


Vesely MD

, Gower WR Jr, Perez-Lamboy G, Overton RM, Gaddy L, Vesely, DL. Evidence for an atrial natriuretic peptide-like gene in plants. Exp Biol Med. 2001; 226(1): 61-5.


Swann JB,

Vesely MD

, Silva A, Sharkey J, Akira S, Schreiber RD, and Smyth MJ.

Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis. Proc Natl Acad Sci U S A. 2008; 105(2): 652-6


Vesely MD

, Kershaw MH, Schreiber RD, and Smyth MJ. Natural Innate and Adaptive Immunity to Cancer. Annu Rev of Immunol. 2011; 29: 235-71.


Matsushita H*,

Vesely MD*

, Koboldt DC, Rickert CG, Uppaluri R, Magrini, V, Arthur C, White JM, Chen YS, Shea LK, Hundal J, Wendl MC, Demeter R, Wylie T, Allison JP, Smyth MJ, Mardis ER, Old LJ, and Schreiber RD. Cancer Exome Analysis Reveals a T Cell Dependent Mechanism of Cancer Immunoediting. Nature. 2012; 482: 400-404


Teng MWL,

Vesely MD

, Duret H, McLaughlin N, Schwendener R, Towne JE, Schreiber RD, and Smyth MJ. Opposing roles for IL-23 and IL-12 in maintaining occult cancer in an equilibrium state. Cancer Research. 2012. 72 (16): 3987-96


Vesely MD

and Robert Schreiber. Cancer immunoediting: antigens, mechanisms, and implications to cancer therapy. Annals of New York Academy of Science. 2013. 1284 (1):1-5


Gubin MM, Zhang X, Schuster H, Caron E, Noguchi T, Ward JP, Ivanova Y, Hundal J, Arthur CD, Krebber WJ, Mulder GE, Vesely MD, Lam SSK, Korman AJ, Allison JP, Freeman GJ, Sharpe AH, Pearce EL, Aebersold R, Rammensee HG, Melief CJM, Mardis ER, Gillanders WE, Artyomov MN, and Robert D. Schreiber

. Checkpoint Blockade Cancer Immunotherapy Targets Tumour-Specific Mutant Antigens. Nature. Manuscript under review.